Longboard Stock Soars on FDA Designations for Epilepsy Drug

Imugene gets crucial FDA nod for bile tract cancer drug

thewest.com.au - 18/Sep 06:47

Imugene has landed a prized FDA orphan drug approval for its bile tract cancer therapy following positive results from its recent metastatic advanced...

Imugene gets crucial FDA nod for bile tract cancer drug

thewest.com.au - 18/Sep 06:47

Imugene has landed a prized FDA orphan drug approval for its bile tract cancer therapy following positive results from its recent metastatic advanced...

FDA Grants Traditional Approval to Retevmo (selpercatinib) for Medullary Thyroid Cancer with a RET Mutation

drugs.com - 27/Sep 03:09

On September 27, 2024, the Food and Drug Administration granted traditional approval to selpercatinib (Retevmo, Eli Lilly and Company) for adult and...

FDA Grants Traditional Approval to Retevmo (selpercatinib) for Medullary Thyroid Cancer with a RET Mutation

drugs.com - 27/Sep 03:09

On September 27, 2024, the Food and Drug Administration granted traditional approval to selpercatinib (Retevmo, Eli Lilly and Company) for adult and...

FDA Approves Miplyffa (arimoclomol) for the Treatment of Niemann-Pick Disease Type C

drugs.com - 20/Sep 05:09

CELEBRATION, Fla., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare...

FDA Approves Aqneursa (levacetylleucine) for the Treatment of Niemann-Pick Disease Type C

drugs.com - 25/Sep 07:09

AUSTIN, TX, September 25, 2024– IntraBio Inc., a leader in the discovery and development of innovative drugs for rare neurodegenerative...

FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease

drugs.com - 01/Oct 22:48

TUESDAY, Oct. 1, 2024 -- The U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with...

APLT Stock Soars 69% on Positive Update on Galactosemia Drug NDA

zacks.com - 19/Sep 15:53

Applied Therapeutics stock surges 69% as the FDA says that no advisory committee meeting is required to discuss the govorestat NDA for classic...

Dupixent Approved in the US as the First-Ever Biologic Medicine for Patients with COPD

drugs.com - 27/Sep 21:09

Paris and Tarrytown, NY, September 27, 2024. The US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance...

Dupixent Approved in the US as the First-Ever Biologic Medicine for Patients with COPD

drugs.com - 27/Sep 21:09

Paris and Tarrytown, NY, September 27, 2024. The US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance...

Rubriques :

Longboard Stock Soars on FDA Designations for Epilepsy Drug

Articles similaires

Imugene gets crucial FDA nod for bile tract cancer drug

Imugene gets crucial FDA nod for bile tract cancer drug

FDA Grants Traditional Approval to Retevmo (selpercatinib) for Medullary Thyroid Cancer with a RET Mutation

FDA Grants Traditional Approval to Retevmo (selpercatinib) for Medullary Thyroid Cancer with a RET Mutation

FDA Approves Miplyffa (arimoclomol) for the Treatment of Niemann-Pick Disease Type C

FDA Approves Aqneursa (levacetylleucine) for the Treatment of Niemann-Pick Disease Type C

FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease

APLT Stock Soars 69% on Positive Update on Galactosemia Drug NDA

Dupixent Approved in the US as the First-Ever Biologic Medicine for Patients with COPD

Dupixent Approved in the US as the First-Ever Biologic Medicine for Patients with COPD

Les derniers communiqués